
Dr. Kara Fitzgerald discusses gut resilience and microbiome science with Colleen Cutcliffe, focusing on strategies for IBS-prone patients.
As more patients present with digestive sensitivity and increasingly restricted diets, restoring gut resilience has become a central clinical challenge. In this episode of New Frontiers in Functional Medicine, Dr. Kara Fitzgerald speaks with Colleen Cutcliffe, PhD, CEO and co-founder of Pendulum Therapeutics, about emerging microbiome science and practical strategies for supporting microbial balance, dietary tolerance, and metabolic health. The discussion explores next-generation probiotic strains, fiber diversity, IBS patterns, and real-world approaches clinicians can use to help patients rebuild microbiome resilience and expand diet diversity in practice. Full show notes + references: https://www.drkarafitzgerald.com/fxmed-podcast/ GUEST DETAILS Colleen Cutcliffe, PhD, is CEO and Co-Founder of Pendulum Therapeutics, where she focuses on advancing microbiome science and metabolic health through next-generation probiotic research. She holds a PhD in Biochemistry and Molecular Biology from Johns Hopkins University and brings more than 25 years of experience across biotechnology, pharmaceuticals, and academic research. THANKS TO OUR SPONSOR Pendulum Therapeutics…
Host: Dr. Kara Fitzgerald
Guest: Colleen Cutcliffe
Pendulum Therapeutics
Organizations: PendulumLife.com, Johns Hopkins University
Explore listener stats, chart rankings, contacts and more on the Dr. Kara Fitzgerald | New Frontiers in Functional Medicine, Longevity, Epigenetics podcast page.